当前位置:首页 - 行情中心 - 启迪药业(000590) - 财务分析 - 现金流量表

启迪药业

(000590)

  

流通市值:28.68亿  总市值:28.69亿
流通股本:2.39亿   总股本:2.39亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金173,900,130.4242,260,219.97425,064,352.77313,769,905.77
  收到其他与经营活动有关的现金69,750,067.9615,986,571.4634,903,187.7721,255,906.35
  经营活动现金流入小计243,650,198.3858,246,791.43459,967,540.54335,025,812.12
  购买商品、接受劳务支付的现金71,094,983.7134,785,343.82185,794,264.06126,074,197.56
  支付给职工以及为职工支付的现金77,030,515.1648,503,544135,073,622.56107,457,738.16
  支付的各项税费30,613,272.8511,076,497.6236,356,190.8629,638,893.68
  支付其他与经营活动有关的现金33,961,206.5517,672,384.8985,355,490.1957,947,922.07
  经营活动现金流出小计212,699,978.27112,037,770.33442,579,567.67321,118,751.47
  经营活动产生的现金流量净额30,950,220.11-53,790,978.917,387,972.8713,907,060.65
二、投资活动产生的现金流量:
  收回投资收到的现金135,000,00065,000,000260,000,000130,000,000
  取得投资收益收到的现金299,874.9161,696.82536,643.55236,020.14
  处置固定资产、无形资产和其他长期资产收回的现金净额22,00022,00014,1602,000
  投资活动现金流入小计135,321,874.965,183,696.82260,550,803.55130,238,020.14
  购建固定资产、无形资产和其他长期资产支付的现金27,300,778.758,025,04932,102,860.6126,010,404.73
  投资支付的现金135,000,00065,000,000260,000,000160,000,000
  投资活动现金流出小计162,300,778.7573,025,049292,102,860.61186,010,404.73
  投资活动产生的现金流量净额-26,978,903.85-7,841,352.18-31,552,057.06-55,772,384.59
三、筹资活动产生的现金流量:
  吸收投资收到的现金--350,000350,000
  其中:子公司吸收少数股东投资收到的现金--350,000350,000
  取得借款收到的现金42,830,821.0833,054,890.3638,111,890.9236,257,920
  收到其他与筹资活动有关的现金5,000,000--100,000
  筹资活动现金流入小计47,830,821.0833,054,890.3638,461,890.9236,707,920
  偿还债务支付的现金5,000,000-34,887,92025,000,000
  分配股利、利润或偿付利息支付的现金1,781,417.39838,508.693,555,326.932,590,090.4
  其中:子公司支付给少数股东的股利、利润--90,000-
  支付其他与筹资活动有关的现金1,513,351.58233,706.663,329,557.722,149,084.03
  筹资活动现金流出小计8,294,768.971,072,215.3541,772,804.6529,739,174.43
  筹资活动产生的现金流量净额39,536,052.1131,982,675.01-3,310,913.736,968,745.57
五、现金及现金等价物净增加额43,507,368.37-29,649,656.07-17,474,997.92-34,896,578.37
  加:期初现金及现金等价物余额160,588,687.75160,588,687.75178,063,685.67178,063,685.67
  期末现金及现金等价物余额204,096,056.12130,939,031.68160,588,687.75143,167,107.3
补充资料:
  净利润-17,263,541.22--127,230,053.08-
  资产减值准备640.48-119,237,884.73-
  固定资产和投资性房地产折旧11,304,627.01-20,039,039.32-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧11,304,627.01-20,039,039.32-
  无形资产摊销3,293,234.28-6,286,584.32-
  长期待摊费用摊销807,362.4-888,050.24-
  处置固定资产、无形资产和其他长期资产的损失-3,444,349.77--4,780.83-
  固定资产报废损失845.53-266,521.57-
  公允价值变动损失--871,950.28-
  财务费用1,907,967.66-3,661,916.25-
  投资损失-36,284.33--372,373.55-
  递延所得税-3,787,940.55--4,856,348.81-
  其中:递延所得税资产减少-3,553,823.96--4,566,069.39-
    递延所得税负债增加-234,116.59--290,279.42-
  存货的减少-762,918.77-5,129,522.21-
  经营性应收项目的减少55,866,115.02--4,291,009.21-
  经营性应付项目的增加-11,814,123.51--32,028,291.43-
  其他-6,537,613.08-26,901,757.6-
  现金的期末余额204,096,056.12-160,588,687.75-
  减:现金的期初余额160,588,687.75-178,063,685.67-
  现金及现金等价物的净增加额43,507,368.37--17,474,997.92-
公告日期2025-08-272025-04-282025-03-282024-10-30
审计意见(境内)标准无保留意见
TOP↑